application of tranexamic acid in the pericardial cavity on post-operative blood loss in off-pump CABG.
Methods:
This study is a non-randomized, double blinded, clinical trial, conducted in the department of cardiac surgery, National Institute of Cardiovascular Diseases from January 2014 to December 2015 among the patients admitted for OPCAB surgery. A total 60 number of patients were enrolled for the study. They were randomly assigned in two groups-30 patients in tranexamic acid group (Group I) and 30 patients in placebo group (Group II). On completion of the grafting, before closure of the sternum tranexamic acid (2.5 g/25 ml) or placebo (25 ml of saline) diluted in 100 ml of warm saline (37 °C) was instilled into the pericardial cavity including the mediastinal tissues and left for 5 minutes. Then it was cleared out and sternum was closed. Data were collected using case record collection form from patient's admission up to the discharge of the patient from ICU. Statistical analysis was done using SPSS version 17.0 software.
There was no significant difference noted in baseline demographic data, basic clinical characteristics and preoperative coagulation profile between the 2 groups (P > 0.05). All patients were pre-medicated with tablet midazolam 7.5 mg orally the night before surgery. Injection Morphine sulphate 7.5 mg intramuscularly (I.M.) and tablet Metoprolol 25 mg per orally were given 1 hour before surgery. Standard anesthetic technique including induction, maintenance and recovery were being followed. A median sternotomy was done and at the same time Great saphenous vein and Internal mammary artery was harvested and prepared for the graft. The distal anastomosis with reverse saphenous venous graft was done with partial clamp of aorta. The drainage of the chest tubes were measured hourly and were removed when the total drainage volume of < 50 ml over the previous12 hours and of serous color. Uniform transfusion protocol was applied to all patients. Blood and blood components were administered only when the hematocrit level < 24% or the haemoglobin level d" 8.0 gm/dl in the postoperative period.
Results:
Both groups were compared according to their preoperative clinical and demographical characteristics and there were no significant statistical differences found between them. Similarly, there was no statistically significant difference among the two groups in preoperative hematological characteristics in terms of haematocrit, platelet count, INR, bleeding time and clotting time for bleeding. There was no incidence of MI, thromboembolism, DVT or stroke.
Discussion:
In our study postoperative mediastinal bleeding at 4 hours, 12 hours in group I and group II patients were 116.67±44.2ml vs. 190±44.33 ml (p= 0.000), 345±74.68 ml vs. 511.67±66.54 ml (p= 0.000) respectively. Total postoperative mediastinal bleeding was also significantly lower in tranexamic acid group than in placebo group (421.67±70.32 vs. 593.33±77.38 ml; p= 0.000).
Baric and his colleagues reported cumulative blood loss within 24 h 633± 343 ml in tranexamic acid group and 903± 733ml in placebo group. This study included patients undergoing coronary surgery, valve surgery and other cardiac surgeries. The tranexamic acid group received 2.5 gm tranexamic acid in 250 ml normal saline and the other group received 250 ml of normal saline in the pericardial cavity and over the mediastinal tissue before median sternotomy closure. 15 Hossein and his colleagues reported to enroll 71 patients in prospective study and grouped patients into two groups. In tranexamic acid group median of postoperative bleeding at the end of 24 hours was 366ml in comparison to 788ml in placebo group bearing significant difference. Though he used lower amount of tranexamic acid (1 gm) in his study. 16 Nouraei and his colleagues reported total blood loss in Tranexamic acid group to be 313±173ml and 454±268 ml in control group (p<0.01). In the study tranexamic acid (2 g/20 mL) or placebo (20 mL of saline) was diluted in 500 mL of warm saline (37°C ), poured into the pericardial cavity, and left for 5 min on completion of CABG (on pump) before sternotomy wound closure. The volume of blood loss were similar to our study. 17 Aoki and his colleagues reported that the volume of blood loss in 24 h after intensive care unit admission was 492±180 ml in control group and 303±112 ml in tranexamic acid group (p<0.0001). They investigated 100 consecutive patients undergoing off-pump coronary artery bypass. In the study group 10 mL of a solution containing 1 g of tranexamic acid was sprayed into the pericardial cavity and mediastinum before the sternum was closed. Our study showed similar volume of blood loss. 18 
Conclusion:
The result of this study allows us to conclude that the topical application of tranexamic acid leads to reduction of blood loss after off-pump CABG procedure. In addition it decreases whole blood transfusion requirement after CABG surgery. 
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